| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MUS.20785 |
| P698 | PubMed publication ID | 17469109 |
| P2093 | author name string | Douglas W Zochodne | |
| P2860 | cites work | Altered microvascular reactivity to endothelin-1, endothelin-3 and NG-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus | Q30992328 |
| The role of oxidative stress and NF-kappaB activation in late diabetic complications | Q33803284 | ||
| Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy | Q34472568 | ||
| Structure, regulation and function of PKB/AKT--a major therapeutic target | Q35692051 | ||
| Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats | Q35755591 | ||
| Diabetes mellitus and the sensory neuron | Q35816806 | ||
| Quantitation of epidermal nerves in diabetic neuropathy | Q36825566 | ||
| Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture | Q38596574 | ||
| Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study | Q39415678 | ||
| The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy | Q39452399 | ||
| Anticonvulsant drugs for management of pain: a systematic review. | Q39471264 | ||
| Successful treatment of neuropathies in patients with diabetes mellitus | Q40374998 | ||
| Intima of epineurial arterioles is increased in diabetic polyneuropathy | Q44098020 | ||
| The spectrum of neuropathy in diabetes and impaired glucose tolerance | Q44276740 | ||
| Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial | Q44374546 | ||
| Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial | Q44743462 | ||
| Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects | Q45057234 | ||
| Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial | Q45185821 | ||
| Ganglion-specific patterns of diabetes-modulated gene expression are established in prevertebral and paravertebral sympathetic ganglia prior to the development of neuroaxonal dystrophy. | Q54690690 | ||
| P433 | issue | 2 | |
| P921 | main subject | nervous system | Q9404 |
| P304 | page(s) | 144-166 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Muscle and Nerve | Q15764281 |
| P1476 | title | Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms | |
| P478 | volume | 36 |
| Q37528638 | A Role for Insulin in Diabetic Neuropathy |
| Q38841846 | Activity for Diabetic Polyneuropathy (ADAPT): Study Design and Protocol for a 2-Site Randomized Controlled Trial. |
| Q57031178 | Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice |
| Q35568131 | Angioblast Derived from ES Cells Construct Blood Vessels and Ameliorate Diabetic Polyneuropathy in Mice |
| Q27028046 | Animal models of peripheral neuropathies |
| Q36029829 | Application of Heart Rate Variability in Diagnosis and Prognosis of Individuals with Diabetes Mellitus: Systematic Review. |
| Q33864721 | Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials |
| Q35180081 | Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice |
| Q37297622 | Calcium, parathyroid hormone, and vitamin D: major determinants of chronic pain in hemodialysis patients |
| Q37400722 | Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy |
| Q34850807 | Cellular changes in diabetic and idiopathic gastroparesis |
| Q34855100 | Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy |
| Q46342383 | Changes in sensory function and force production in adults with type II diabetes |
| Q38175969 | Concepts for regulation of axon integrity by enwrapping glia |
| Q53159863 | Correlation of diabetic retinopathy and corneal neuropathy using confocal microscopy. |
| Q50328302 | Cutaneous manifestations of diabetic peripheral neuropathy |
| Q42081490 | Development of sensory neuropathy in streptozotocin-induced diabetic mice |
| Q43778631 | Diabetic Schwann cells suffer from nerve growth factor and neurotrophin-3 underproduction and poor associability with axons |
| Q52658260 | Diabetic neuropathy and the sensory neuron: New aspects of pathogenesis and their treatment implications. |
| Q36293649 | Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? |
| Q41866847 | Diabetic polyneuropathy, sensory neurons, nuclear structure and spliceosome alterations: a role for CWC22. |
| Q37485844 | Differential expression of neuregulin-1 isoforms and downregulation of erbin are associated with Erb B2 receptor activation in diabetic peripheral neuropathy |
| Q42247670 | Direct Conversion of Human Fibroblasts into Schwann Cells that Facilitate Regeneration of Injured Peripheral Nerve In Vivo |
| Q34073266 | Early detection of atrophy of foot muscles in Chinese patients of type 2 diabetes mellitus by high-frequency ultrasonography |
| Q37846329 | Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety |
| Q38208484 | Evaluation of ranirestat for the treatment of diabetic neuropathy |
| Q47676300 | Evidence for Epigenetic Regulation of Gene Expression and Function in Chronic Experimental Diabetic Neuropathy. |
| Q39408557 | Feasibility testing of smart tablet questionnaires compared to paper questionnaires in an amputee rehabilitation clinic |
| Q99240788 | Functional neuroimaging of sensorimotor cortices in postmenopausal women with type II diabetes |
| Q33593046 | Global transcriptional programs in peripheral nerve endoneurium and DRG are resistant to the onset of type 1 diabetic neuropathy in Ins2 mice |
| Q38457192 | High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes |
| Q36214692 | Hyperglycemic tumor microenvironment induces perineural invasion in pancreatic cancer |
| Q38924963 | IRS proteins and diabetic complications |
| Q43173273 | Immunohistochemical study of vasoactive intestinal peptide (VIP) enteric neurons in diabetic rats supplemented with L-glutamine |
| Q42090409 | In vivo peripheral nervous system insulin signaling |
| Q35095336 | Insulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathy |
| Q41820385 | Intranasal insulin ameliorates experimental diabetic neuropathy |
| Q57119115 | L-glutamine supplementation prevents myenteric neuron loss and has gliatrophic effects in the ileum of diabetic rats |
| Q38248720 | Low vitamin B12 in patients on admission to an amputation rehabilitation unit: a retrospective study |
| Q53130138 | Medial plantar-to-radial amplitude ratio: does it have electrodiagnostic utility in distal sensory polyneuropathy? |
| Q41681334 | Modulatory effect of fibre-enriched cake on alloxan-induced diabetic toxicity in rat brain tissues. |
| Q54596963 | Motor end plate innervation loss in diabetes and the role of insulin. |
| Q93081165 | Nerves and Pancreatic Cancer: New Insights into a Dangerous Relationship |
| Q39455313 | Neuroactive steroids and diabetic complications in the nervous system. |
| Q34277175 | Neutralization of schwann cell-secreted VEGF is protective to in vitro and in vivo experimental diabetic neuropathy |
| Q40035868 | Novel systems for in vivo monitoring and microenvironmental investigations of diabetic neuropathy in a murine model |
| Q36084076 | Overexpression of human HSP27 protects sensory neurons from diabetes |
| Q50265071 | Peripheral neuropathy is a common manifestation of mitochondrial diseases: a single-centre experience |
| Q35579658 | Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice |
| Q87971391 | Physical Training and Activity in People With Diabetic Peripheral Neuropathy: Paradigm Shift |
| Q37139753 | Physiology in Medicine: neuromuscular consequences of diabetic neuropathy |
| Q38675106 | Predictive Value of Glycated Hemoglobin and Body Mass Index for Pretreatment Neuropathy in Patients With Multiple Myeloma. |
| Q35691639 | Protective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozosin |
| Q33840959 | Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia |
| Q43089816 | Restless legs syndrome and diabetic neuropathy |
| Q37793315 | Schwann Cells as a Therapeutic Target for Peripheral Neuropathies |
| Q42291779 | Sensitivity, Specificity and Predictive Value of Heart Rate Variability Indices in Type 1 Diabetes Mellitus |
| Q24338727 | Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling |
| Q33682322 | Tangluoning, a traditional Chinese medicine, attenuates in vivo and in vitro diabetic peripheral neuropathy through modulation of PERK/Nrf2 pathway |
| Q46752589 | The effect of spinal cord stimulation frequency in experimental painful diabetic polyneuropathy |
| Q33635281 | The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy |
| Q35511977 | Therapeutic Benefit of Extended Thymosin β4 Treatment Is Independent of Blood Glucose Level in Mice with Diabetic Peripheral Neuropathy |
| Q47159384 | Transplantation of dental pulp stem cells improves long-term diabetic polyneuropathy together with improvement of nerve morphometrical evaluation |
| Q38194034 | Use of natural compounds in the management of diabetic peripheral neuropathy. |
| Q34459107 | Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice |
| Q83277976 | Visual sensitivity loss in the central 30° of visual field is associated with diabetic peripheral neuropathy |
| Q53444023 | Vitamin E supplementation in rats with experimental diabetes mellitus: analysis of myosin-V and nNOS immunoreactive myenteric neurons from terminal ileum. |
| Q89134632 | [Diabetic neuropathy] |
| Q64944828 | [Polyneuropathies in the elderly. Classification and thematic review]. |
Search more.